NuGEN Technologies, Inc., a market leader in the development of innovative sample preparation solutions for Next Generation Sequencing (NGS) applications, has announced the NuGEN 2014 Genomics Grant Challenge.
This is the fourth year that NuGEN has funded a $10,000 grant challenge. "This program has been well-received by the scientific community year after year, and we expect the grant challenge for target enrichment-focused studies to draw strong participation this year," commented Doug Amorese, VP of R&D for NuGEN. "We look forward to receiving the study proposals and to catalyzing research efforts that may be stalled due to lack of funding. We were impressed by the high caliber of study designs received last year."
"There are many promising research projects that don't receive NIH grants, as funding has been more difficult to secure in recent years," stated Elizabeth Hutt, CEO of NuGEN. "We are pleased to play a role in supporting biomedical research again this year with the Genomics Grant Challenge. Enabling genomic research projects to move forward not only advances discovery, but benefits the broader community. Through this initiative we are able to demonstrate our on-going commitment to life science."
NuGEN is accepting non-confidential study proposals until July 31, 2014. All abstract submission will be reviewed and the winning proposal will be selected by a scientific committee, with the winner being notified on August 28, 2014. The 2014 Genomics Grant Challenge Award recipient will receive up to $10,000 of Ovation® Target Enrichment System reagents for targeted sequencing studies.